These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 24291639

  • 1. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H, Gao S, Ye J, Feng X, Cai Y, Liu Z, Lu J, Li Q, Huang X, Chen S, Liu P.
    Mol Cell Endocrinol; 2014 Feb 15; 382(2):998-1006. PubMed ID: 24291639
    [Abstract] [Full Text] [Related]

  • 2. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
    Le K, Li R, Xu S, Wu X, Huang H, Bao Y, Cai Y, Lan T, Moss J, Li C, Zou J, Shen X, Liu P.
    Arch Biochem Biophys; 2012 Feb 01; 518(1):71-8. PubMed ID: 22198280
    [Abstract] [Full Text] [Related]

  • 3. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H, Jia G, Liu X, Liu Z, Wang H.
    Environ Toxicol Pharmacol; 2014 Jul 01; 38(1):263-71. PubMed ID: 24975447
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of TRPC1 in the development of cardiac hypertrophy.
    Ohba T, Watanabe H, Murakami M, Takahashi Y, Iino K, Kuromitsu S, Mori Y, Ono K, Iijima T, Ito H.
    J Mol Cell Cardiol; 2007 Mar 01; 42(3):498-507. PubMed ID: 17174323
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K.
    Circulation; 2005 Jun 14; 111(23):3095-104. PubMed ID: 15939815
    [Abstract] [Full Text] [Related]

  • 6. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K.
    Cardiovasc Ther; 2009 Jun 14; 27(1):17-27. PubMed ID: 19207476
    [Abstract] [Full Text] [Related]

  • 7. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY, Huang H, Jiang H, Shen DF, Yan L, Zhu LH, Wang L, Cao F, Liu C, Tang QZ, Li H.
    Hypertension; 2010 Feb 14; 55(2):257-63. PubMed ID: 20026769
    [Abstract] [Full Text] [Related]

  • 8. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X, Li J, Wang X, Chen N, Cai B, Wang G, Shan H, Dong D, Liu Y, Li X, Yang F, Li X, Zhang P, Li X, Yang B, Lu Y.
    Int J Biol Sci; 2011 Apr 07; 7(3):383-9. PubMed ID: 21494433
    [Abstract] [Full Text] [Related]

  • 9. Sildenafil prevents the up-regulation of transient receptor potential canonical channels in the development of cardiomyocyte hypertrophy.
    Kiso H, Ohba T, Iino K, Sato K, Terata Y, Murakami M, Ono K, Watanabe H, Ito H.
    Biochem Biophys Res Commun; 2013 Jul 05; 436(3):514-8. PubMed ID: 23764398
    [Abstract] [Full Text] [Related]

  • 10. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X, Xia J, Qian D, Wang Y, Lin Y, Huang X, Tan J.
    Cardiology; 2014 Jul 05; 129(3):153-62. PubMed ID: 25277512
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 12. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.
    Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, Luo JD.
    Circulation; 2004 Sep 07; 110(10):1269-75. PubMed ID: 15313952
    [Abstract] [Full Text] [Related]

  • 13. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B, Tan X, Zhang Y, Li X, Wang X, Zhu J, Wang Y, Yang F, Wang B, Liu Y, Xu C, Pan Z, Wang N, Yang B, Lu Y.
    Stem Cells Transl Med; 2015 Dec 07; 4(12):1425-35. PubMed ID: 26586774
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced COX-2 expression and hypertrophy in primary human cardiomyocytes.
    Chien PT, Lin CC, Hsiao LD, Yang CM.
    Toxicol Appl Pharmacol; 2015 Dec 01; 289(2):349-59. PubMed ID: 26385185
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Wang BH, Bertucci MC, Ma JY, Adrahtas A, Cheung RY, Krum H.
    Clin Exp Pharmacol Physiol; 2010 Sep 01; 37(9):912-8. PubMed ID: 20497423
    [Abstract] [Full Text] [Related]

  • 17. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
    Cheng TH, Shih NL, Chen CH, Lin H, Liu JC, Chao HH, Liou JY, Chen YL, Tsai HW, Chen YS, Cheng CF, Chen JJ.
    J Biomed Sci; 2005 Sep 01; 12(1):123-33. PubMed ID: 15864745
    [Abstract] [Full Text] [Related]

  • 18. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S, Tang F, Yang Y, Lu M, Luan A, Zhang J, Yang J, Wang H.
    PLoS One; 2015 Sep 01; 10(3):e0118759. PubMed ID: 25738576
    [Abstract] [Full Text] [Related]

  • 19. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF, Hsu JH, Chen YT, Chen IJ, Yeh JL.
    Molecules; 2015 Jun 05; 20(6):10435-49. PubMed ID: 26056815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.